Latest news and press releases about DarioHealth Corp. (DRIO): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management.
Price
| Price | $6.78 |
| Market Cap | $50M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 9.83 |
| Price / Book | 1.15 |
| EV / EBITDA | -2.65 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 104.15% |
| Return on Invested Capital | -78.42% |
| Return on Assets | 70.17% |
| Gross Margin | 56.09% |
| Operating Margin | -328.83% |
| Net Margin | 322.77% |
Related companies: ABSI · AVNS · FLGT · INNV · MYGN · NNNN · OFIX
Explore sector: Healthcare · Medical - Specialties
More sections of DRIO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks